๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase-II study ofcis-diammine-dichloro platinum (cis-platinum), bleomycin and methotrexate for advanced squamous cell carcinoma of head and neck

โœ Scribed by P. Espana; F. Smith; J. Abrams; D. Haidak; W. Ueno; P. Woolley; P. Schein


Book ID
104684892
Publisher
Springer
Year
1984
Tongue
English
Weight
258 KB
Volume
12
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

โœฆ Synopsis


Twenty-one patients with head and neck carcinomas relapsing after radiotherapy were treated with a combination of cis-platinum, bleomycin, and methotrexate. Four patients (19%) achieved a partial response. Toxicity was significant in selected cases; three patients developed WBC counts less than 1,000/mm3 and one of these patients died with sepsis. Severe mucositis was present in three of the twenty-one patients. Considering the toxicity of this combination and the limited therapeutic activity with the dose and schedule used in this study, this regimen is not recommended for the treatment of squamous head and neck carcinomas relapsing after radiotherapy.


๐Ÿ“œ SIMILAR VOLUMES


Phase II trial of cis-diamminedichloropl
โœ Dr. Kazuo Tamura; Yasuhiko Araki; Hiromichi Tateyama; Moritaka Maeda; Masashi Se ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 407 KB

Advanced squamous cell carcinoma of the head and neck, lung, esophagus, and uterine cervix is still a challenging cancer to the medical practice. We have treated 23 such patients with a combination of cis-platinum, vincristine, and peplomycin. Cis-platinum was given at a dose of 60 mg/ m2 on day 1,

Preoperative simultaneously administered
โœ Slotman, Gus J. ;Cummings, Frank J. ;Glicksman, Arvin R. ;Doolittle, Charles L. ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› Wiley (John Wiley & Sons) โš– 547 KB

Synchronously administered cis-platinum (cis-DDP) and radiation therapy have been used to treat unresectable squamous cell carcinomas of the head and neck. The purpose of this study was to evaluate the efficacy and tolerance of preoperative adjuvant cis-DDP plus radiation therapy in operable stage I

Phase II study of mitoxantrone in advanc
โœ Stephen D. Williams; Robert Birch; Enrique Velez-Garcia; Richard Gams ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer US ๐ŸŒ English โš– 170 KB

A phase II study of mitoxantrone in squamous cell carcinoma of head and neck origin was conducted. Fiftythree evaluable patients were treated with this agent at a dosage of 5 mg/M2/week. The majority of patients were of high performance status. Twenty-seven patients had received previous chemotherap

Combination of cis-platinum and bleomyci
โœ Joseph L. Pennacchio; Waun Ki Hong; Stanley Shapshay; Thomas Gillis; Charles Vau ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 621 KB

Forty-one patients with unresectable Stage IV head and neck squamous cell carcinoma were treated with combined modality therapy (CM) consisting of induction chemotherapy followed by surgery and/ or radiotherapy (RT). Treatment and survival results are reported and compared to results obtained in tre